Zimbabwe has turned down a substantial US healthcare agreement worth 367 million US dollars (£272m) spanning five years due to the United States' demand for confidential biological samples.
This move came to light after a official document dated December was leaked, revealing that President Emmerson Mnangagwa felt the arrangement was "lopsided".
A government spokesperson later explained that the United States was requesting health data for research and commercial purposes while was not willing to share the benefits from future medical innovations.
"We will now turn to the challenging and unfortunate process of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had provided more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged continued dialogue to reach a deal acceptable to all parties so the country's vital HIV programme can continue.
Broader Implications
This rejection follows a similar case in neighbouring Kenya, where a high court halted a related deal with the US following legal challenges were raised about the security of Kenyans' medical information.
After returning to the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed aid for the American government, but Trump claimed its expenditure was "inefficient" and his government was pursuing government-to-government deals to enhance transparency and accountability.
According to reports, Sixteen African countries have to date agreed to these new agreements, representing over $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration would have delivered extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving HIV treatment through US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, without any corresponding guarantee of access to any scientific breakthroughs – such as new medicines or tests – that might be developed from that shared data," his statement read.
"In essence, our country would supply the basic resources for medical research without any certainty that the final treatments would be available to our people if a future disease outbreak emerge."
National Interest and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting frameworks previously established through the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.
"This system is intended to ensure that when a country contributes its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to create them."
These objections over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We are open to ongoing discussions with our American counterparts on how future co-operation could be structured in a manner that honours the sovereignty and interests of both nations."
Medical Community Response
Medical experts expressed it understood the official position, but suggested that talks should continue since a large portion of the nation's Aids initiatives were funded by international support.
"Where technical issues arise, including those relating to information security or implementation frameworks, these can frequently be resolved via technical clarification and negotiated safeguards," the group said.
The situation highlights the ongoing challenges between accepting vital international aid and safeguarding local interests in an ever more data-driven world.